Drug Development - Targeting HER2 beyond Trastuzumab

被引：0
|
作者：
Spector, N. L. [1 ]
机构：
[1] Duke Univ, Med Ctr, Durham, NC USA
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/0008-5472.SABCS10-PL2-1
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
PL2-1
引用
收藏
页数：1
相关论文
共 50 条
  • [31] BEYOND OVEREXPRESSION/AMPLIFICATION OF HER2
    Viale, Giuseppe
    BREAST, 2021, 59 : S27 - S27
  • [32] Two Dimensions in Targeting HER2
    Moasser, Mark M.
    JOURNAL OF CLINICAL ONCOLOGY, 2014, 32 (19) : 2074 - U125
  • [33] Targeting HER2 in colorectal cancer
    Spitzer, Eleonore
    Cervera, Pascale
    Andre, Thierry
    Cohen, Romain
    BULLETIN DU CANCER, 2023, 110 (04) : 402 - 411
  • [34] Tolerability and efficacy of targeting both mTOR and HER2 signaling in trastuzumab-refractory HER2+metastatic breast cancer
    Gajria, D.
    King, T.
    Pannu, H.
    Sakr, R.
    Modi, S.
    Drullinsky, P.
    Syldor, A.
    Path, S.
    Seidman, A.
    Norton, L.
    Rosen, N.
    Hudis, C.
    Chandarlapaty, S.
    CANCER RESEARCH, 2012, 72
  • [35] TARGETING HER2 WITH TRASTUZUMAB-DM1 (T-DM1) IN HER2-OVEREXPRESSING BLADDER CANCER
    Hayashi, Tetsutaro
    Jaeger, Wolfgang
    Moskalev, Igor
    Awrey, Shannon
    Li, Na
    Fazli, Ladan
    Yasui, Wataru
    Matsubara, Akio
    Black, Peter
    JOURNAL OF UROLOGY, 2014, 191 (04): : E301 - E301
  • [36] Inhibitor development targeting HER2 incorporating bridging water molecules
    Guo, Jiaye
    Rizzo, Robert
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [37] Antibody-Drug Conjugates in Breast Cancer: What Is Beyond HER2?
    Nicolo, Eleonora
    Repetto, Matteo
    Bielo, Luca Boscolo
    Tarantino, Paolo
    Curigliano, Giuseppe
    CANCER JOURNAL, 2022, 28 (06): : 436 - 445
  • [38] DOTAGA-Trastuzumab. A New Antibody Conjugate Targeting HER2/Neu Antigen for Diagnostic Purposes
    Moreau, Mathieu
    Raguin, Olivier
    Vrigneaud, Jean-Marc
    Collin, Bertrand
    Bernhard, Claire
    Tizon, Xavier
    Boschetti, Frederic
    Duchamp, Olivier
    Brunotte, Francois
    Denat, Franck
    BIOCONJUGATE CHEMISTRY, 2012, 23 (06) : 1181 - 1188
  • [39] HER2 Targeting Peptides Screening and Applications in Tumor Imaging and Drug Delivery
    Geng, Lingling
    Wang, Zihua
    Jia, Xiangqian
    Han, Qiuju
    Xiang, Zhichu
    Li, Dan
    Yang, Xiaoliang
    Zhang, Di
    Bu, Xiangli
    Wang, Weizhi
    Hu, Zhiyuan
    Fang, Qiaojun
    THERANOSTICS, 2016, 6 (08): : 1261 - 1273
  • [40] Dual targeting of HER2: Enhanced antitumor efficacy of trastuzumab-DM1 combined with pertuzumab
    Fields, Carter T.
    Crocker, Lisa M.
    Sliwkowski, Mark X.
    Phillips, Gail D. Lewis
    CANCER RESEARCH, 2010, 70
12345